Intra-Cellular Therapies Inc. buy Bank of America Co.
Start price
18.04.24
/
50%
€68.50
Target price
18.04.25
€85.29
Performance (%)
-2.92%
Price
03.09.24
€66.50
Summary
This prediction is currently active. With a performance of -2.92%, the BUY prediction for Intra-Cellular Therapies Inc. by Bank_of_America_Co_ is down slightly. This prediction currently runs until 18.04.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 0.000% | 0.000% |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Bank of America Co. from $82.00 to $91.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
02.01.24
02.01.24
€74.81
02.01.25
02.01.25
4.72%
03.09.24
03.09.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€58.10
29.03.24
29.03.24
22.14%
30.03.24
30.03.24